← Evidence map

ReviewCureus2026

GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide)/GLP-1 Receptor Agonists for Antipsychotic-Induced Weight Gain: A Narrative Review.

Agnieszka Buczkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide)/GLP-1 Receptor Agonists for Antipsychotic-Induced Weight Gain: A Narrative Review. | OpenQuestion